Cargando…
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
Here we discuss antibody, cell and gene-based therapies that are currently available and under investigation for both wet and dry age-related macular degeneration (AMD). We initially discuss ocular anatomy, AMD modelling as well as the underlying pathophysiology of AMD. The antibody-based trials whi...
Autores principales: | Akyol, Engin, Lotery, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494004/ https://www.ncbi.nlm.nih.gov/pubmed/32982165 http://dx.doi.org/10.2147/BTT.S252581 |
Ejemplares similares
-
Epigenetics in age-related macular degeneration: new discoveries and future perspectives
por: Gemenetzi, M., et al.
Publicado: (2020) -
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
por: Warwick, Alasdair, et al.
Publicado: (2014) -
Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
por: Khan, Adnan H., et al.
Publicado: (2023) -
Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014) -
Epigenetic Age Acceleration Is Not Associated with Age-Related Macular Degeneration
por: Saptarshi, Neil, et al.
Publicado: (2021)